A bill to secure the supply of drugs in the United States, and for other purposes.

Bill 118 s 5638, also known as the "Secure Drug Supply Act," is a piece of legislation introduced in the United States Congress with the goal of ensuring a stable and secure supply of drugs in the country. The bill aims to address issues related to drug shortages, counterfeit drugs, and other threats to the pharmaceutical supply chain.

The Secure Drug Supply Act includes provisions that require drug manufacturers to report potential shortages of essential medications to the Food and Drug Administration (FDA) in a timely manner. This reporting requirement is intended to help the FDA and other relevant agencies take proactive measures to prevent or mitigate drug shortages that could impact patient care.

Additionally, the bill includes measures to enhance the security and integrity of the pharmaceutical supply chain, such as requiring the use of track-and-trace technology to monitor the movement of drugs from manufacturer to distributor to pharmacy. This technology is designed to help prevent the distribution of counterfeit or adulterated drugs and improve the ability to trace the source of any potential safety concerns. Overall, the Secure Drug Supply Act is aimed at safeguarding the availability and safety of medications for patients in the United States. By addressing issues related to drug shortages and counterfeit drugs, the bill seeks to ensure that Americans have access to the medications they need to maintain their health and well-being.